Miracle Mile Advisors »

Corvus Pharmaceuticals shares owned by Miracle Mile Advisors

Quarter-by-quarter ownership of Corvus Pharmaceuticals (CRVS) shares owned by Miracle Mile Advisors from 13F filings

Historical chart of Miracle Mile Advisors investment in Corvus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Corvus Pharmaceuticals held by Miracle Mile Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corvus Pharmaceuticals by Miracle Mile Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $439k 30k 14.63

More positions owned by Miracle Mile Advisors

Schwab Strategic Tr Intl Eqty Etf (SCHF)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Spdr Series Trust State Street Spd (SPYM)
Apple (AAPL)
Ishares Tr Mbs Etf (MBB)
Spdr Series Trust State Street Spd (BIL)
Microsoft Corporation (MSFT)
Ishares Tr Eafe Value Etf (EFV)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Goldman Sachs Etf Tr Acces Treasury (GBIL)
Ishares Tr Ishs 1-5yr Invs (IGSB)
Ishares Tr A Rate Cp Bd Etf (QLTA)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
NVIDIA Corporation (NVDA)

View all positions for Miracle Mile Advisors

Top funds holding Corvus Pharmaceuticals

OrbiMed Advisors
BlackRock
Vanguard Group
Adams Street Partners
Point72 Asset Management
State Street Corporation
MPM Oncology Impact Management
Vivo Capital
Geode Capital Management
Foresite Capital Management VI
DCF Advisers
Perceptive Advisors
Millennium Management
Susquehanna International
Goldman Sachs Group

View all funds holding Corvus Pharmaceuticals